These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2998977)

  • 1. [Is CMV-hyperimmune serum prophylaxis after kidney transplantation always meaningful?].
    Greger B; Kurth J; Schareck WD; Müller GH; Hopt UT; Bockhorn H
    Immun Infekt; 1985 Sep; 13(5):215-9. PubMed ID: 2998977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CMV hyperimmune globulin prophylaxis does not prevent CMV disease in CMV-negative renal transplant patients.
    Pakkala S; Salmela K; Lautenschlager I; Ahonen J; Häyry P
    Transplant Proc; 1992 Feb; 24(1):283-4. PubMed ID: 1311472
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytomegalovirus hyperimmunoglobulin prophylaxis in the prevention of cytomegalovirus infection in immunosuppressed heart transplant patients.
    Havel M; Teufelsbauer H; Laczkovics A; Kurz R; Wolner E
    Transplant Proc; 1990 Aug; 22(4):1805-6. PubMed ID: 2167533
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cytomegalovirus infections after kidney transplantation and passive immunization].
    Wienand P; Grundmann R; Runde A; Zippel C
    Immun Infekt; 1985 Sep; 13(5):203-9. PubMed ID: 2998975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodies.
    Said T; Nampoory MR; Johny KV; Pacsa AS; Mini Abraham P; Nair MP; Abdel-Haleem M; Samhan M; Al-Mousawi M
    Transplant Proc; 2004; 36(6):1847-9. PubMed ID: 15350495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.
    Falagas ME; Snydman DR; Ruthazer R; Griffith J; Werner BG; Freeman R; Rohrer R
    Clin Transplant; 1997 Oct; 11(5 Pt 1):432-7. PubMed ID: 9361936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of cytomegalovirus infections in renal transplant patients treated with conventional or cyclosporin therapy.
    Guerin C; Pozzetto B; Genin C; Berthoux FC; Gaudin OG
    Nephrol Dial Transplant; 1988; 3(1):77-80. PubMed ID: 2837679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Incidence and clinical relevance of cytomegalovirus diseases using cyclosporine compared to conventional immunosuppression].
    Wilms H; Kirste G; Neumann-Häfelin D
    Immun Infekt; 1985 Sep; 13(5):220-3. PubMed ID: 2998978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganciclovir prophylaxis to prevent CMV disease in kidney recipients undergoing anti-lymphocyte globulin treatment for acute rejection.
    Dickenmann MJ; Kabulbayev K; Steiger J; Cathomas G; Reusser P; Tamm M
    Clin Microbiol Infect; 2004 Apr; 10(4):337-9. PubMed ID: 15059125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction with and without antithymocyte globulin combined with cyclosporine/tacrolimus-based immunosuppression in renal transplantation: a meta-analysis of randomized controlled trials.
    Tian JH; Wang X; Yang KH; Liu AP; Luo XF; Zhang J
    Transplant Proc; 2009 Nov; 41(9):3671-6. PubMed ID: 19917365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis.
    Bonaros N; Mayer B; Schachner T; Laufer G; Kocher A
    Clin Transplant; 2008; 22(1):89-97. PubMed ID: 18217909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus immunoglobulins in the prevention and treatment of cytomegalovirus disease.
    Snydman DR
    Rev Infect Dis; 1990; 12 Suppl 7():S839-48. PubMed ID: 2173113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased Cytomegalovirus infection after antilymphocyte therapy in sirolimus-treated renal transplant patients.
    Ozaki KS; Câmara NO; Galante NZ; Camargo LF; Pacheco-Silva A
    Int Immunopharmacol; 2005 Jan; 5(1):103-6. PubMed ID: 15589467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early detection of primary cytomegalovirus infection after heart and kidney transplantation and the influence of hyperimmune globulin prophylaxis.
    Boland GJ; Ververs C; Hené RJ; Jambroes G; Donckerwolcke RA; de Gast GC
    Transpl Int; 1993 Jan; 6(1):34-8. PubMed ID: 8267694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytomegalovirus hyperimmune globulin prophylaxis in bone marrow transplants in children with various diseases].
    Ebell W; Blütters-Sawatzki R; Friedrich W; Hampl W; Kleihauer E
    Immun Infekt; 1985 Nov; 13(6):307-12. PubMed ID: 3000925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single center randomized trial using ATG v OKT3 treatment in steroid resistant rejection crises after kidney transplantation.
    Blümke M; Kirste G; Wanner U; Wilms H
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1747. PubMed ID: 2652571
    [No Abstract]   [Full Text] [Related]  

  • 18. A randomized prospective trial of oral versus intravenous ganciclovir for prophylaxis of cytomegalovirus infection and disease in high-risk kidney recipients.
    Nafar M; Pezeshki ML; Farrokhi F; Einollahi B; Pour-Reza-Gholi F; Firouzan A; Farhangi S
    Transplant Proc; 2005 Sep; 37(7):3053-5. PubMed ID: 16213302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus prophylaxis in pediatric renal transplant recipients.
    So S; Mayo C; McCullough C; Jendrisak M; Woodle S; Marsh W; Bailey T
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1414-5. PubMed ID: 8382865
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of cytomegalovirus (CMV)-specific T cell immune reconstitution revealed that baseline antiviral immunity, prophylaxis, or preemptive therapy but not antithymocyte globulin treatment contribute to CMV-specific T cell reconstitution in kidney transplant recipients.
    Abate D; Saldan A; Fiscon M; Cofano S; Paciolla A; Furian L; Ekser B; Biasolo MA; Cusinato R; Mengoli C; Bonfante L; Rossi B; Rigotti P; Sgarabotto D; Barzon L; Palù G
    J Infect Dis; 2010 Aug; 202(4):585-94. PubMed ID: 20594105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.